Computed tomography assessment of myocardial perfusion, viability, and function

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 6, 2004, Pages 800-815

  Koyama, Yasushi ^a,c   Mochizuki, Teruhito ^b   Higaki, Jitsuo ^b  

^a Ehime Prefectural Imabari Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Ehime Prefectural Imabari Hospital   (Japan)

Author keywords

CT; Function; Myocardial perfusion; Nuclear medicine; Viability

Indexed keywords

PYROPHOSPHATE TECHNETIUM TC 99M; THALLIUM 201;

CELL VIABILITY; CLASSIFICATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED MULTIDETECTOR SPIRAL COMPUTED TOMOGRAPHY; CONTRAST ENHANCED SINGLE SLICE DETECTOR COMPUTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FUTUROLOGY; HEALING; HEART FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART PERFUSION; HUMAN; ISOTOPE LABELING; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THICKNESS;

CORONARY CIRCULATION; HEART; HUMANS; TISSUE SURVIVAL; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR FUNCTION, LEFT;

EID: 2942701987     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20067     Document Type: Review

References (82)

1. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125-130.
2. Abe M, Kazatani Y, Fukuda H, Tatsuno H, Habara H, Shinbata H. Left ventricular volumes, ejection fraction, and regional wall motion calculated with gated technetium-99m tetrofosmin SPECT in reperfused acute myocardial infarction at super-acute phase: comparison with left ventriculography. J Nucl Cardiol 2000;7:569-574.
3. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 1997;38:577-581.
4. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-1383.
5. Rogers Jr WJ, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999;99:744-750.
6. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
7. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
8. Matsunaka T, Hamada M, Matsumoto Y, Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI: relation to regional contractile function and wall thickness of the left ventricle. Magnetic Resonance in Medical Sciences 2003;2:61-69.
9. Kim RJ, Judd RM. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 2003;41:1568-1572.
10. Bogaert J, Maes A, Van de Werf F, et al. Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular function. Circulation 1999;99:36-43.
11. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-1705.
12. Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation 2000;101:2368-2374.
13. Nieman K, Oudkerk M, Rensing BJ, et al. Coronary angiography with multi-slice computed tomography. Lancet 2001;357:599-603.
14. Achenbach S, Ulzheimer S, Baum U, et al. Noninvasive coronary angiography by retrospectively ECG-gated multislice spiral CT. Circulation 2000;102:2823-2828.
15. Becker CR, Ohnesorge BM, Schoepf UJ, Reiser MF. Current development of cardiac imaging with multidetector-row CT. Eur J Radiol 2000;36:97-103.
16. Willmann JK, Weishaupt D, Lachat M, et al. Electrocardiographically gated multi-detector row CT for assessment of valvuler morphology and calcification in aortic stenosis. Radiology 2002;225:120-128.
17. Mochizuki T, Murase K, Higashino H, et al. Two- and three-dimensional CT ventriculography: a new application of helical CT. AJR Am J Roentgenol 2000;174:203-208.
18. Koyama Y, Matsuoka H, Higashino H, et al. Four-dimensional cardiac image by helical computed tomography. Circulation 1999;100: E61-E62.
19. Kachelriess M, Sennst DA, Maxlmoser W, Kalender WA. Kymogram detection and kymogram-correlated image reconstruction from subsecond spiral computed tomography scans of the heart. Med Phys 2002;29:1489-1503.
20. Hamada S, Naito H, Takamiya M. Evaluation of myocardium in ischemic heart disease by ultrafast computed tomography. Jpn Circ J 1992;56:627-631.
21. Naito H, Saito H, Takamiya M, et al. Quantitative assessment of myocardial enhancement with iodinated contrast medium in patients with ischemic heart disease by using ultrafast x-ray computed tomography. Invest Radiol 1992;27:436-442.
22. Naito H, Saito H, Ohta M, Takamiya M. Significance of ultrafast computed tomography in cardiac imaging: usefulness in assessment of myocardial characteristics and cardiac function. Jpn Circ J 1990;54:322-327.
23. Mochizuki T, Murase K, Higashino H, Koyama Y, Azemoto S, Ikezoe J. Images in cardiovascular medicine. Demonstration of acute myocardial infarction by subsecond spiral computed tomography: early defect and delayed enhancement. Circulation 1999;99:2058-2059.
24. Koyama Y, Matsuoka T, Kawakami H, et al. Myocardial perfusion patterns by two-phase contrast CT predict clinical outcome in patients with acute myocardial infarction after successful reperfusion therapy. Jpn Circ J 2002;66(Suppl 1):813.
25. Koyama Y, Matsuoka H, Higashino H, et al. Wall motion and wall thickness analysis after receiving successful reperfusion therapy in acute myocardial infarction: an assessment of early perfusion defect by enhanced helical CT [in Japanese, abstract in English]. Jpn J Interv Cardiol 2001;16:233-242.
26. Koyama Y, Matsuoka H, Higasino H, et al. Assessment of myocardial infarct volume by contrast enhancement CT. Radiology 2001;221(Suppl P):196.
27. Koyama Y, Matsuoka H, Higasino H, et al. Assessment of myocardial infarct size by contrast enhanced CT. Circulation 2001;104(Suppl):II-477.
28. Koyama Y, Matsuoka H, Higasino H, et al. Early myocardial perfusion defect and late enhancement on enhancement CT predict clinical outcome in patients with acute myocardial infarction after reperfusion therapy. Radiology 2001;221(Suppl P):196.
29. Koyama Y, Matsuoka H, Mochizuki T, et al. Myocardial perfusion pattern of healing stages in patients with acute myocardial infarction after successful reperfusion therapy by two-phase contrast CT predicts clinical outcome. Circulation 2002;106(Suppl):II-1-II-440.
30. Koyama Y, Matsuoka H, Higashino H, Kawakami H, Ito T, Mochizuki T. Myocardial perfusion pattern by two-phase contrast CT predicts clinical outcome in patients with acute myocardial infarction after successful reperfusion therapy. Radiology 2002;225(Suppl P):153.
31. 18f]fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-1015.
32. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-1014.
33. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985;76:1713-1719.
34. Wu K, Zerhouni E, Judd R, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.
35. Mutzel W, Speck U, Weinmann HJ. Pharmacokenetics of iopromide in rat and dog. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd 1983;118:85-90. [Ger]
36. Allard M, Doucet D, Kien P, Bonnemain B, Caille JM. Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties. Invest Radiol 1988;23(Suppl 1):S271-S274.
37. Tauber U, Mutzel W, Schulze PE. Whole body autoradiographic distribution studies on nonionic x-ray contrast agents in pregnant rats. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd 1989;128:215-219. [Ger]
38. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
39. Yokota C, Nonogi H, Miyazaki S, et al. Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. Am J Cardiol 1995;75:577-581.
40. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
41. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
42. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-644.
43. Kitagawa K, Sakuma H, Hirano T, Okamoto S, Makino K, Takeda K. Acute myocardial infarction: myocardial viability assessment in patients early thereafter-comparison of contrast-enhanced MR imaging with resting (201) T1 SPECT. Single photon emission computed tomography. Radiology 2003;226:138-144.
44. Kramer CM, Rogers WJ, Mankad S, et al. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000;36:1835-1840.
45. Oshinski JN, Yang Z, Jones JR, et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-2842.
46. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
47. Ellis SG, O'Neill WW, Bates E, Walton JA, Nabel EG, Topol EJ. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. J Am Coll Cardiol 1989;13:1122-1126.
48. Honan MB, Harrell Jr FE, Reimer KA, et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;16:359-367.
49. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium: the open artery hypothesis [Review]. Circulation 1993;88:2426-2436.
50. Yusuf S, Collins R, Petro R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side effects for 33 randomized controlled trials. Eur Heart J 1985;6:566-585.
51. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-766.
52. Richard V, Murry CE, Reimer KA. Healing of myocardial infarcts in dogs: effects of late reperfusion. Circulation 1995;92:1891-1901.
53. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932-936.
54. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med 1993;329:1615-1622.
55. Van de Werf F. Discrepancies between the effects of coronary reperfusion on survival and left ventricular function. Lancet 1989;1:1367-1369.
56. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993;21:1391-1395.
57. Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL, Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. J Am Coll Cardiol 1992;19:1-10.
58. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation 1993;87:1829-1839.
59. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
60. Gold HK, Garabedian HD, Dinsmore RE, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: observations in animals and humans. Circulation 1997;95:1755-1759.
61. Brener SJ, Barr LA, Burchenal JEB, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-741.
62. Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-1199.
63. Fugit MD, Rubal BJ, Donovan DJ. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. J Invasive Cardiol 2000;12:80-85.
64. Assali AR, Sdringola S, Ghani M, et al. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon. Cathet Cardiovasc Interv 2000;51:27-31.
65. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-660.
66. Wang HJ, Kao HL, Liau CS, Lee YT. Export aspiration catheter thrombosuction before actual angioplasty in primary coronary intervention for acute myocardial infarction. Cathet Cardiovasc Interv 2002;57:332-339.
67. Kalaria VG, Rouch C, Bourdillon PD, Breall JA. Distal emboli protection in patients undergoing percutaneous coronary intervention after a recent myocardial infarction. Cathet Cardiovasc Interv 2002;57:54-60.
68. Bolli R. Myocardial 'stunning' in man. Circulation 1992;86:1671-1691.
69. Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial 'stunning': a clinically relevant phenomenon. Ann Intern Med 1988;108:626-629.
70. Kloner RA, Przyklenk K, Patel B. Altered myocardial states: the stunned and hibernating myocardium. Am J Med 1989;86(Suppl 1A):14-22.
71. Kloner RA, Przyklenk K, Rahimtoola S, Braunwald E. Myocardial stunning and hibernation: mechanisms and clinical implications. In: Braunwald E, editor. Heart disease: update II. Philadelphia, PA: WB Saunders; 1990. p 241-256.
72. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Karl S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol 1989;13:1506-1513.
73. Stack RS, Phillips HR, Grierson D, et al. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J Clin Invest 1983;72:84-95.
74. Sheehan FH, Doerr R, Schmidt WG, et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coll Cardiol 1988;12:289-300.
75. Reduto LA, Freund GC, Gaeta JM, Smalling RW, Lewis B, Gould KL. Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance. Am Heart J 1981;102:1168-1177.
76. Mochizuki T, Higashino H, Koyama Y, et al. Clinical usefulness of the cardiac multi-detector-row CT. Comput Med Imaging Graph 2003;27:35-42.
77. Hosoi S, Mochizuki T, Miyagawa M, Shen Y, Murase K, Ikezoe J. Assessment of left ventricular volumes using multi-detector row computed tomography (MDCT): phantom and human studies. Radiat Med 2003;21:62-67.
78. Becker CR, Ohnesorge BM, Schoepf UJ, Reiser MF. Current development of cardiac imaging with multidetector-row CT. Eur J Radiol 2000;36:97-103.
79. Mochizuki T, Murase K, Koyama Y, Higashino H, Ikezoe J. LAD stenosis detected by subsecond spiral CT. Circulation 1999;99:1523.
80. Mochizuki T, Koyama Y, Tanaka H, Ikezoe J, Shen Y, Azemoto S. Left ventricular thrombus detected by two- and three-dimensional computed tomographic ventriculography: a new application of helical CT. Circulation 1998;98:933-934.
81. Koyama Y, Matsuoka H, Higasino H, et al. Four-dimensional cardiac image by helical computed tomography. Circulation 1999;100: e61-e62.
82. Koyama Y, Matsuoka H, Higashino H, et al. Left ventricular hypertrophy demonstrated by four-dimensional myocardiography by helical computed tomography. Circulation 2001;103:e15-e17.